Formulation and evaluation of transdermal patches of diclofenac sodium

Glossary definitions and references:

Scientific and Ayurvedic Glossary list for “Formulation and evaluation of transdermal patches of diclofenac sodium”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.

1) Drug:
Drugs are chemical substances used in the treatment, cure, prevention, or diagnosis of diseases. The study focuses on NSAIDs, specifically Diclofenac Sodium, highlighting their therapeutic potential while discussing the advantages of transdermal patches over conventional oral routes, particularly regarding absorption and side effects.

2) Table:
In research papers, tables are utilized to present data in a structured format, facilitating easy comparison and analysis. They provide a clear summary of variables, results, and methods, allowing readers to quickly grasp complex information. In this study, tables showcase the composition of the transdermal patch and evaluation results.

3) Sahu:
Sahu refers to Gyanesh Kumar Sahu, the corresponding author of the study. As the principal investigator, Sahu plays a crucial role in conducting the research and presenting findings. His expertise in pharmaceutical sciences is essential for developing effective transdermal delivery systems and ensuring the integrity of the research.

4) Swelling:
Swelling refers to the ability of the transdermal patch to absorb fluids and expand. It is an important characteristic that can influence the release of the drug from the patch. Evaluating the swelling index helps determine the suitability of the formulation for effective drug delivery through the skin.

5) Surface:
Surface characteristics of a transdermal patch, such as texture, pH, and morphology, are critical for its performance. The surface needs to be compatible with the skin to ensure good adhesion and drug absorption. An optimal surface also enhances the patient's comfort and contributes to an effective delivery system.

6) Study (Studying):
Study in this context refers to the research conducted to formulate and evaluate Diclofenac Sodium transdermal patches. It encompasses several experimental methodologies aimed at improving drug delivery systems, assessing drug stability, release kinetics, and the overall effectiveness of the patches in managing conditions like pain and inflammation.

7) Water:
Water serves as both a solvent and a medium in the formulation of transdermal patches. It is often mixed with other solvents, such as ethanol, to dissolve polymers and active ingredients. Proper hydration of the system is crucial for the patch's stability, integrity, and drug release profile.

8) Shri (Sri, Sr):
Shri is a respectful prefix used in India, typically in conjunction with the names of people, particularly those in academia or professions. In this case, it precedes 'Shankracharya Technical Campus,' signifying respect for the institution associated with Sahu, the lead author of the study.

9) Life:
Life in this context may refer to the biological half-life of Diclofenac Sodium, which is significant for understanding how long the drug remains active in the body after administration. Longer half-lives can allow for less frequent dosing, improving patient compliance and therapeutic outcomes.

10) Inflammation:
Inflammation is a biological response to harmful stimuli, often presenting with redness, swelling, pain, and heat. In this study, the aim is to use Diclofenac Sodium, an anti-inflammatory drug, to manage inflammatory conditions effectively through a transdermal delivery system, optimizing therapeutic benefits.

11) Science (Scientific):
Science represents the systematic enterprise that builds and organizes knowledge in the form of testable explanations and predictions about the universe. In the context of this study, scientific methods are employed to investigate the properties, formulations, and effectiveness of transdermal patches containing Diclofenac Sodium.

12) Campu:
The term likely refers to 'Campus,' as found in 'Shri Shankracharya Technical Campus.' This institution is involved in the education and research of pharmaceutical sciences, which is critical for conducting the study. The campus provides facilities and resources necessary for the development and evaluation of drug delivery systems.

13) Pain:
Pain is an unpleasant sensory experience that often signals injury or illness. The study focuses on using Diclofenac Sodium, an NSAID, in transdermal patches aimed at providing localized and systemic pain relief while avoiding the side effects associated with oral intake, thus improving patient comfort.

14) Shankaracarya (Shankara-acarya, Sankaracarya, Sankaracharya):
Shankaracharya refers to the educational institution, namely the Shri Shankracharya Technical Campus, where the research is conducted. The emphasis on this institution shows the importance of academic collaboration in pharmaceutical research which is fundamental for the development of innovative drug delivery systems.

15) Toxicity:
Toxicity refers to the degree to which a substance can harm humans or animals. In drug formulation, it’s vital to assess the safety profile of medications, including potential side effects. The study aims to create a transdermal patch of Diclofenac Sodium with reduced systemic toxicity compared to conventional dosages.

16) Activity:
Activity typically refers to the pharmacological effects or actions of a drug. In this context, it pertains to the effectiveness of Diclofenac Sodium in providing relief from pain and inflammation. The formulation's ability to deliver a therapeutic dose through the skin relies on its bioactivity.

17) Kumar:
Kumar likely refers to Gyanesh Kumar Sahu, one of the authors of the study. His involvement indicates a collaborative effort in conducting the research, analyzing results, and contributing to the field of pharmaceutical sciences, particularly in drug delivery mechanisms and formulation techniques.

18) Blood:
Blood circulation is crucial for the effective delivery of drugs administered via transdermal patches. The goal is to ensure that the drug diffuses through the skin into the bloodstream efficiently for the desired therapeutic effect. Drug formulation must consider permeability and absorption characteristics.

19) Food:
Food intake can influence drug absorption and effectiveness. In the case of Diclofenac Sodium, its pharmacokinetic profile suggests that food may delay absorption when taken orally, highlighting the advantage of a transdermal system that bypasses the gastrointestinal tract and offers more consistent plasma levels.

20) Pur:
Poor refers to aspects such as inadequate drug absorption or therapeutic outcomes. In the study, addressing the challenges associated with the conventional delivery of Diclofenac Sodium, which can result in poor bioavailability, is crucial. Therapeutic delivery via transdermal patches aims to improve absorption and effectiveness.

21) Rheumatoid arthritis:
Rheumatoid arthritis is a chronic inflammatory disorder causing pain and disability. The research supports the formulation of transdermal patches to manage pain and inflammation related to this condition, emphasizing the need for effective, long-term, and patient-friendly therapeutic alternatives in managing symptoms.

22) Dysmenorrhea (Dysmenorrhoea):
Dysmenorrhea refers to painful menstruation, a condition often treated with NSAIDs like Diclofenac Sodium. The study explores transdermal delivery to alleviate pain associated with dysmenorrhea more effectively than oral administration, thereby improving comfort and convenience for patients during menstruation.

23) Srivastava (Sri-vastava, Shrivastava, Shri-vastava):
Akarshi Shrivastava is likely a contributing author in the study. The role of all authors, including Shrivastava, is significant in the research process, where collaboration is necessary for successful findings and advancements in pharmaceutical formulations and therapeutic applications.

24) Observation:
Observation refers to the systematic examination or assessment of the transdermal patches during the study. It includes monitoring the physical properties and evaluating the efficacy of the formulations. Observational data supports understanding the results and improving future formulations, enhancing overall research quality.

25) Discussion:
Discussion involves analyzing and interpreting the findings from the study. It synthesizes the results and draws conclusions regarding the effectiveness and safety of the transdermal patches of Diclofenac Sodium, elaborating on the implications of the data for future research and clinical applications.

26) Irritation:
Irritation pertains to the adverse skin reactions potentially caused by topical formulations. The study seeks to formulate a transdermal patch that minimizes irritation while ensuring effective drug delivery. Evaluating skin tolerance is vital for patient compliance and the overall success of transdermal systems.

27) Vomiting:
Vomiting is a common side effect associated with many NSAIDs when taken orally. The study aims to present a transdermal alternative for administering Diclofenac Sodium to avoid gastrointestinal disturbances, including nausea and vomiting, thus enhancing patient comfort and adherence to treatment regimens.

28) Bleeding:
Bleeding refers to serious side effects associated with NSAID use, particularly gastrointestinal bleeding. The research aims to develop a transdermal delivery system for Diclofenac Sodium that minimizes the risk of such adverse effects, enhancing safety and therapeutic efficacy for patients requiring anti-inflammatory treatment.

29) Animal:
Animal studies are crucial in pharmacological research to evaluate the safety and efficacy of new formulations. The insights gained from using animal models inform researchers about potential human responses to drugs, ensuring that the developed transdermal systems operate effectively and safely.

30) Family:
Family in this context may refer to a category of related drugs, such as NSAIDs, that share similar properties. Diclofenac Sodium is part of this pharmaceutical family, allowing for comparative studies and understanding trends in drug efficacy and safety across this drug class.

31) Nausea:
Nausea is a significant side effect of many oral medications, including NSAIDs. The study seeks to design a transdermal patch of Diclofenac Sodium that offers effective analgesia without causing nausea, thus improving patient compliance and satisfaction with their treatment regimen.

32) Sharman (Sarma, Sharma, Sarman):
Sharma refers to Harish Sharma, one of the authors of the study. His contributions, along with those of co-authors, are essential in conducting research, analyzing data, and delivering findings that enhance the field of pharmaceutical sciences, particularly in drug formulation and delivery methodologies.

33) Reason:
Reason refers to the justification for conducting the study. The increasing need for effective pain management solutions without the drawbacks of traditional oral NSAIDs underscores the importance of developing a transdermal patch for Diclofenac Sodium, targeting efficiency and patient comfort.

34) Medium:
Medium in this context refers to the vehicle for drug delivery, which can pertain to solvents or membranes used in formulating transdermal patches. The choice of medium directly affects drug solubility, release kinetics, and the overall effectiveness of the patch in delivering therapeutic compounds.

35) Filling (Filled):
Filled can refer to the process of adding active ingredients to the formulation used for preparing transdermal patches. The way the patches are filled or loaded with drug is critical to ensuring consistent drug release rates and effective topical absorption for therapeutic efficacy.

36) Ulcer:
An ulcer is a sore on the skin or mucous membrane that can be caused by various factors, including medication use. The study emphasizes the importance of avoiding such complications by utilizing transdermal delivery for Diclofenac Sodium, aimed at enhanced safety and therapeutic outcomes.

37) Hair:
Hair is significant in the context of the study as it pertains to the preparation of goat skin used in in-vitro drug diffusion studies. Removing hair is necessary to ensure optimal contact and accurate measurement for the permeability and effectiveness of transdermal patches.

38) Hand:
Hand may refer to the precision required in laboratory techniques for formulating and evaluating transdermal patches. Proper handling during preparation and testing is crucial to ensure the quality and efficacy of the final product, impacting overall research outcomes.

39) Milk:
Milk can be indicative of bioavailability studies where the presence of the drug in breast milk is assessed. This aspect is particularly important when considering the safety of drug usage during lactation, addressing the implications of drug formulations like Diclofenac Sodium for nursing mothers.

40) Dish (Dis):
Dish in this context refers to Petri dishes used in the laboratory for preparing transdermal patches. These dishes provide a controlled environment for the casting process, allowing for precise formulation and evaluation of physical properties of the patches after solvent evaporation.